The global Recombinant Human Chorionic Gonadotropin market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Intramuscular Powder for Injection Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Recombinant Human Chorionic Gonadotropin include Ferring Pharmaceuticals, Schering Plough, Serum International Ltd, Merck, Wellona Pharma, Bionomics Lifesciences, Marvel Oceanic Private Limited and Facmed Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Chorionic Gonadotropin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Chorionic Gonadotropin. This report contains market size and forecasts of Recombinant Human Chorionic Gonadotropin in global, including the following market information:
Global Recombinant Human Chorionic Gonadotropin Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Recombinant Human Chorionic Gonadotropin Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Recombinant Human Chorionic Gonadotropin companies in 2023 (%)
We surveyed the Recombinant Human Chorionic Gonadotropin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Chorionic Gonadotropin Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Recombinant Human Chorionic Gonadotropin Market Segment Percentages, by Type, 2023 (%)
Intramuscular Powder for Injection
Subcutaneous Solution for Injection
Global Recombinant Human Chorionic Gonadotropin Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Recombinant Human Chorionic Gonadotropin Market Segment Percentages, by Application, 2023 (%)
Female
Male
Global Recombinant Human Chorionic Gonadotropin Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Recombinant Human Chorionic Gonadotropin Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Chorionic Gonadotropin revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Recombinant Human Chorionic Gonadotropin revenues share in global market, 2023 (%)
Key companies Recombinant Human Chorionic Gonadotropin sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Recombinant Human Chorionic Gonadotropin sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ferring Pharmaceuticals
Schering Plough
Serum International Ltd
Merck
Wellona Pharma
Bionomics Lifesciences
Marvel Oceanic Private Limited
Facmed Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Human Chorionic Gonadotropin, market overview.
Chapter 2: Global Recombinant Human Chorionic Gonadotropin market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Human Chorionic Gonadotropin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Human Chorionic Gonadotropin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Human Chorionic Gonadotropin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Human Chorionic Gonadotropin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Human Chorionic Gonadotropin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Human Chorionic Gonadotropin Overall Market Size
2.1 Global Recombinant Human Chorionic Gonadotropin Market Size: 2023 VS 2030
2.2 Global Recombinant Human Chorionic Gonadotropin Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Recombinant Human Chorionic Gonadotropin Sales: 2019-2030
3 Company Landscape
3.1 Top Recombinant Human Chorionic Gonadotropin Players in Global Market
3.2 Top Global Recombinant Human Chorionic Gonadotropin Companies Ranked by Revenue
3.3 Global Recombinant Human Chorionic Gonadotropin Revenue by Companies
3.4 Global Recombinant Human Chorionic Gonadotropin Sales by Companies
3.5 Global Recombinant Human Chorionic Gonadotropin Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Recombinant Human Chorionic Gonadotropin Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Recombinant Human Chorionic Gonadotropin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Human Chorionic Gonadotropin Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Human Chorionic Gonadotropin Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Human Chorionic Gonadotropin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Human Chorionic Gonadotropin Market Size Markets, 2023 & 2030
4.1.2 Intramuscular Powder for Injection
4.1.3 Subcutaneous Solution for Injection
4.2 By Type - Global Recombinant Human Chorionic Gonadotropin Revenue & Forecasts
4.2.1 By Type - Global Recombinant Human Chorionic Gonadotropin Revenue, 2019-2024
4.2.2 By Type - Global Recombinant Human Chorionic Gonadotropin Revenue, 2025-2030
4.2.3 By Type - Global Recombinant Human Chorionic Gonadotropin Revenue Market Share, 2019-2030
4.3 By Type - Global Recombinant Human Chorionic Gonadotropin Sales & Forecasts
4.3.1 By Type - Global Recombinant Human Chorionic Gonadotropin Sales, 2019-2024
4.3.2 By Type - Global Recombinant Human Chorionic Gonadotropin Sales, 2025-2030
4.3.3 By Type - Global Recombinant Human Chorionic Gonadotropin Sales Market Share, 2019-2030
4.4 By Type - Global Recombinant Human Chorionic Gonadotropin Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Human Chorionic Gonadotropin Market Size, 2023 & 2030
5.1.2 Female
5.1.3 Male
5.2 By Application - Global Recombinant Human Chorionic Gonadotropin Revenue & Forecasts
5.2.1 By Application - Global Recombinant Human Chorionic Gonadotropin Revenue, 2019-2024
5.2.2 By Application - Global Recombinant Human Chorionic Gonadotropin Revenue, 2025-2030
5.2.3 By Application - Global Recombinant Human Chorionic Gonadotropin Revenue Market Share, 2019-2030
5.3 By Application - Global Recombinant Human Chorionic Gonadotropin Sales & Forecasts
5.3.1 By Application - Global Recombinant Human Chorionic Gonadotropin Sales, 2019-2024
5.3.2 By Application - Global Recombinant Human Chorionic Gonadotropin Sales, 2025-2030
5.3.3 By Application - Global Recombinant Human Chorionic Gonadotropin Sales Market Share, 2019-2030
5.4 By Application - Global Recombinant Human Chorionic Gonadotropin Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Recombinant Human Chorionic Gonadotropin Market Size, 2023 & 2030
6.2 By Region - Global Recombinant Human Chorionic Gonadotropin Revenue & Forecasts
6.2.1 By Region - Global Recombinant Human Chorionic Gonadotropin Revenue, 2019-2024
6.2.2 By Region - Global Recombinant Human Chorionic Gonadotropin Revenue, 2025-2030
6.2.3 By Region - Global Recombinant Human Chorionic Gonadotropin Revenue Market Share, 2019-2030
6.3 By Region - Global Recombinant Human Chorionic Gonadotropin Sales & Forecasts
6.3.1 By Region - Global Recombinant Human Chorionic Gonadotropin Sales, 2019-2024
6.3.2 By Region - Global Recombinant Human Chorionic Gonadotropin Sales, 2025-2030
6.3.3 By Region - Global Recombinant Human Chorionic Gonadotropin Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Recombinant Human Chorionic Gonadotropin Revenue, 2019-2030
6.4.2 By Country - North America Recombinant Human Chorionic Gonadotropin Sales, 2019-2030
6.4.3 US Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.4.4 Canada Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.4.5 Mexico Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Recombinant Human Chorionic Gonadotropin Revenue, 2019-2030
6.5.2 By Country - Europe Recombinant Human Chorionic Gonadotropin Sales, 2019-2030
6.5.3 Germany Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.5.4 France Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.5.5 U.K. Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.5.6 Italy Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.5.7 Russia Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.5.8 Nordic Countries Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.5.9 Benelux Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Recombinant Human Chorionic Gonadotropin Revenue, 2019-2030
6.6.2 By Region - Asia Recombinant Human Chorionic Gonadotropin Sales, 2019-2030
6.6.3 China Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.6.4 Japan Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.6.5 South Korea Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.6.6 Southeast Asia Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.6.7 India Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Recombinant Human Chorionic Gonadotropin Revenue, 2019-2030
6.7.2 By Country - South America Recombinant Human Chorionic Gonadotropin Sales, 2019-2030
6.7.3 Brazil Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.7.4 Argentina Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Human Chorionic Gonadotropin Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales, 2019-2030
6.8.3 Turkey Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.8.4 Israel Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.8.5 Saudi Arabia Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
6.8.6 UAE Recombinant Human Chorionic Gonadotropin Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Ferring Pharmaceuticals
7.1.1 Ferring Pharmaceuticals Company Summary
7.1.2 Ferring Pharmaceuticals Business Overview
7.1.3 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Major Product Offerings
7.1.4 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales and Revenue in Global (2019-2024)
7.1.5 Ferring Pharmaceuticals Key News & Latest Developments
7.2 Schering Plough
7.2.1 Schering Plough Company Summary
7.2.2 Schering Plough Business Overview
7.2.3 Schering Plough Recombinant Human Chorionic Gonadotropin Major Product Offerings
7.2.4 Schering Plough Recombinant Human Chorionic Gonadotropin Sales and Revenue in Global (2019-2024)
7.2.5 Schering Plough Key News & Latest Developments
7.3 Serum International Ltd
7.3.1 Serum International Ltd Company Summary
7.3.2 Serum International Ltd Business Overview
7.3.3 Serum International Ltd Recombinant Human Chorionic Gonadotropin Major Product Offerings
7.3.4 Serum International Ltd Recombinant Human Chorionic Gonadotropin Sales and Revenue in Global (2019-2024)
7.3.5 Serum International Ltd Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Recombinant Human Chorionic Gonadotropin Major Product Offerings
7.4.4 Merck Recombinant Human Chorionic Gonadotropin Sales and Revenue in Global (2019-2024)
7.4.5 Merck Key News & Latest Developments
7.5 Wellona Pharma
7.5.1 Wellona Pharma Company Summary
7.5.2 Wellona Pharma Business Overview
7.5.3 Wellona Pharma Recombinant Human Chorionic Gonadotropin Major Product Offerings
7.5.4 Wellona Pharma Recombinant Human Chorionic Gonadotropin Sales and Revenue in Global (2019-2024)
7.5.5 Wellona Pharma Key News & Latest Developments
7.6 Bionomics Lifesciences
7.6.1 Bionomics Lifesciences Company Summary
7.6.2 Bionomics Lifesciences Business Overview
7.6.3 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Major Product Offerings
7.6.4 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Sales and Revenue in Global (2019-2024)
7.6.5 Bionomics Lifesciences Key News & Latest Developments
7.7 Marvel Oceanic Private Limited
7.7.1 Marvel Oceanic Private Limited Company Summary
7.7.2 Marvel Oceanic Private Limited Business Overview
7.7.3 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Major Product Offerings
7.7.4 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Sales and Revenue in Global (2019-2024)
7.7.5 Marvel Oceanic Private Limited Key News & Latest Developments
7.8 Facmed Pharmaceuticals
7.8.1 Facmed Pharmaceuticals Company Summary
7.8.2 Facmed Pharmaceuticals Business Overview
7.8.3 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Major Product Offerings
7.8.4 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales and Revenue in Global (2019-2024)
7.8.5 Facmed Pharmaceuticals Key News & Latest Developments
8 Global Recombinant Human Chorionic Gonadotropin Production Capacity, Analysis
8.1 Global Recombinant Human Chorionic Gonadotropin Production Capacity, 2019-2030
8.2 Recombinant Human Chorionic Gonadotropin Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Human Chorionic Gonadotropin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Human Chorionic Gonadotropin Supply Chain Analysis
10.1 Recombinant Human Chorionic Gonadotropin Industry Value Chain
10.2 Recombinant Human Chorionic Gonadotropin Upstream Market
10.3 Recombinant Human Chorionic Gonadotropin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Human Chorionic Gonadotropin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Human Chorionic Gonadotropin in Global Market
Table 2. Top Recombinant Human Chorionic Gonadotropin Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Recombinant Human Chorionic Gonadotropin Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Recombinant Human Chorionic Gonadotropin Revenue Share by Companies, 2019-2024
Table 5. Global Recombinant Human Chorionic Gonadotropin Sales by Companies, (K Units), 2019-2024
Table 6. Global Recombinant Human Chorionic Gonadotropin Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Recombinant Human Chorionic Gonadotropin Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Human Chorionic Gonadotropin Product Type
Table 9. List of Global Tier 1 Recombinant Human Chorionic Gonadotropin Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Human Chorionic Gonadotropin Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Recombinant Human Chorionic Gonadotropin Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Recombinant Human Chorionic Gonadotropin Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Recombinant Human Chorionic Gonadotropin Sales (K Units), 2019-2024
Table 15. By Type - Global Recombinant Human Chorionic Gonadotropin Sales (K Units), 2025-2030
Table 16. By Application ? Global Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Recombinant Human Chorionic Gonadotropin Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Recombinant Human Chorionic Gonadotropin Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Recombinant Human Chorionic Gonadotropin Sales (K Units), 2019-2024
Table 20. By Application - Global Recombinant Human Chorionic Gonadotropin Sales (K Units), 2025-2030
Table 21. By Region ? Global Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Recombinant Human Chorionic Gonadotropin Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Recombinant Human Chorionic Gonadotropin Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Recombinant Human Chorionic Gonadotropin Sales (K Units), 2019-2024
Table 25. By Region - Global Recombinant Human Chorionic Gonadotropin Sales (K Units), 2025-2030
Table 26. By Country - North America Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Recombinant Human Chorionic Gonadotropin Sales, (K Units), 2019-2024
Table 29. By Country - North America Recombinant Human Chorionic Gonadotropin Sales, (K Units), 2025-2030
Table 30. By Country - Europe Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Recombinant Human Chorionic Gonadotropin Sales, (K Units), 2019-2024
Table 33. By Country - Europe Recombinant Human Chorionic Gonadotropin Sales, (K Units), 2025-2030
Table 34. By Region - Asia Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Recombinant Human Chorionic Gonadotropin Sales, (K Units), 2019-2024
Table 37. By Region - Asia Recombinant Human Chorionic Gonadotropin Sales, (K Units), 2025-2030
Table 38. By Country - South America Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Recombinant Human Chorionic Gonadotropin Sales, (K Units), 2019-2024
Table 41. By Country - South America Recombinant Human Chorionic Gonadotropin Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales, (K Units), 2025-2030
Table 46. Ferring Pharmaceuticals Company Summary
Table 47. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product Offerings
Table 48. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Ferring Pharmaceuticals Key News & Latest Developments
Table 50. Schering Plough Company Summary
Table 51. Schering Plough Recombinant Human Chorionic Gonadotropin Product Offerings
Table 52. Schering Plough Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Schering Plough Key News & Latest Developments
Table 54. Serum International Ltd Company Summary
Table 55. Serum International Ltd Recombinant Human Chorionic Gonadotropin Product Offerings
Table 56. Serum International Ltd Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Serum International Ltd Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Recombinant Human Chorionic Gonadotropin Product Offerings
Table 60. Merck Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Merck Key News & Latest Developments
Table 62. Wellona Pharma Company Summary
Table 63. Wellona Pharma Recombinant Human Chorionic Gonadotropin Product Offerings
Table 64. Wellona Pharma Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Wellona Pharma Key News & Latest Developments
Table 66. Bionomics Lifesciences Company Summary
Table 67. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Product Offerings
Table 68. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Bionomics Lifesciences Key News & Latest Developments
Table 70. Marvel Oceanic Private Limited Company Summary
Table 71. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Product Offerings
Table 72. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Marvel Oceanic Private Limited Key News & Latest Developments
Table 74. Facmed Pharmaceuticals Company Summary
Table 75. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product Offerings
Table 76. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Facmed Pharmaceuticals Key News & Latest Developments
Table 78. Recombinant Human Chorionic Gonadotropin Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 79. Global Recombinant Human Chorionic Gonadotropin Capacity Market Share of Key Manufacturers, 2022-2024
Table 80. Global Recombinant Human Chorionic Gonadotropin Production by Region, 2019-2024 (K Units)
Table 81. Global Recombinant Human Chorionic Gonadotropin Production by Region, 2025-2030 (K Units)
Table 82. Recombinant Human Chorionic Gonadotropin Market Opportunities & Trends in Global Market
Table 83. Recombinant Human Chorionic Gonadotropin Market Drivers in Global Market
Table 84. Recombinant Human Chorionic Gonadotropin Market Restraints in Global Market
Table 85. Recombinant Human Chorionic Gonadotropin Raw Materials
Table 86. Recombinant Human Chorionic Gonadotropin Raw Materials Suppliers in Global Market
Table 87. Typical Recombinant Human Chorionic Gonadotropin Downstream
Table 88. Recombinant Human Chorionic Gonadotropin Downstream Clients in Global Market
Table 89. Recombinant Human Chorionic Gonadotropin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Human Chorionic Gonadotropin Segment by Type in 2023
Figure 2. Recombinant Human Chorionic Gonadotropin Segment by Application in 2023
Figure 3. Global Recombinant Human Chorionic Gonadotropin Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Recombinant Human Chorionic Gonadotropin Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Recombinant Human Chorionic Gonadotropin Revenue, 2019-2030 (US$, Mn)
Figure 7. Recombinant Human Chorionic Gonadotropin Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Human Chorionic Gonadotropin Revenue in 2023
Figure 9. By Type - Global Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Recombinant Human Chorionic Gonadotropin Revenue Market Share, 2019-2030
Figure 11. By Type - Global Recombinant Human Chorionic Gonadotropin Sales Market Share, 2019-2030
Figure 12. By Type - Global Recombinant Human Chorionic Gonadotropin Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Recombinant Human Chorionic Gonadotropin Revenue Market Share, 2019-2030
Figure 15. By Application - Global Recombinant Human Chorionic Gonadotropin Sales Market Share, 2019-2030
Figure 16. By Application - Global Recombinant Human Chorionic Gonadotropin Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Recombinant Human Chorionic Gonadotropin Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Recombinant Human Chorionic Gonadotropin Revenue Market Share, 2019-2030
Figure 20. By Region - Global Recombinant Human Chorionic Gonadotropin Sales Market Share, 2019-2030
Figure 21. By Country - North America Recombinant Human Chorionic Gonadotropin Revenue Market Share, 2019-2030
Figure 22. By Country - North America Recombinant Human Chorionic Gonadotropin Sales Market Share, 2019-2030
Figure 23. US Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Recombinant Human Chorionic Gonadotropin Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Recombinant Human Chorionic Gonadotropin Sales Market Share, 2019-2030
Figure 28. Germany Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 29. France Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Recombinant Human Chorionic Gonadotropin Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Recombinant Human Chorionic Gonadotropin Sales Market Share, 2019-2030
Figure 37. China Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 41. India Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Recombinant Human Chorionic Gonadotropin Revenue Market Share, 2019-2030
Figure 43. By Country - South America Recombinant Human Chorionic Gonadotropin Sales Market Share, 2019-2030
Figure 44. Brazil Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Recombinant Human Chorionic Gonadotropin Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales Market Share, 2019-2030
Figure 48. Turkey Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Recombinant Human Chorionic Gonadotropin Revenue, (US$, Mn), 2019-2030
Figure 52. Global Recombinant Human Chorionic Gonadotropin Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Recombinant Human Chorionic Gonadotropin by Region, 2023 VS 2030
Figure 54. Recombinant Human Chorionic Gonadotropin Industry Value Chain
Figure 55. Marketing Channels
